Published in Cancer Weekly, February 2nd, 2010
"The purpose of this study was to determine whether combination IP chemotherapy is superior to single-agent therapy in a mouse model. Nu/Nu mice were injected IP with HT-29 colorectal cancer cells. Animals were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.